Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
Authors
Keywords
-
Journal
npj Vaccines
Volume 6, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-18
DOI
10.1038/s41541-021-00348-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis
- (2020) Aggarwal et al. Vaccines
- Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
- (2020) Yvette Robbins et al. eLife
- MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis
- (2019) Olga Rodriguez Cabo Beltran et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
- (2019) Tadanobu Nagaya et al. Cancer Immunology Research
- Experimental research on the therapeutic effect of MMR vaccine to juvenile-onset recurrent respiratory papillomatosis
- (2019) Yu Wang et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Position statement for the diagnosis and management of anogenital warts
- (2019) C. O'Mahony et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis
- (2019) Clint T. Allen et al. Journal for ImmunoTherapy of Cancer
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
- (2017) Keith Limbach et al. MALARIA JOURNAL
- Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
- (2017) Paul E. Clavijo et al. Oncotarget
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Adenoviruses isolated from wild gorillas are closely related to human species C viruses
- (2013) McVey Duncan et al. VIROLOGY
- Incidence and Human Papillomavirus (HPV) Type Distribution of Genital Warts in a Multinational Cohort of Men: The HPV in Men Study
- (2011) Gabriella M. Anic et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now